Latest Alzheimer's disease News

UMass Lowell professor gets $2.7M Alzheimer's research grant

Sep. 26, 2021 11:26 AM EDT

LOWELL, Mass. (AP) — A University of Massachusetts Lowell researcher has received a $2.7 million federal grant to continue her research into the progression of Alzheimer’s disease. The National Institutes of Health grant will help engineering associate professor...

Ex-Finnish president, Nobel winner has advanced Alzheimer's

Sep. 02, 2021 11:23 AM EDT

HELSINKI (AP) — Former Finnish President and Nobel Peace Prize winner Martti Ahtisaari is suffering from Alzheimer’s disease and has withdrawn from all public activities. The office of the Finnish President Sauli Niinisto said on Thursday that the 84-year-old...

Aiding Alzheimer's Association personal for Broncos, Bowlens

Aug. 18, 2021 15:03 PM EDT

ENGLEWOOD, Colo. (AP) — Denver Broncos coaches ditched their usual navy and orange attire Wednesday for purple T-shirts as the franchise held its third annual Alzheimer’s Awareness Day. “Obviously it's touched this organization in a deep way with the Bowlen family...

Research looks for possible COVID tie to later Alzheimer’s

Jul. 29, 2021 16:02 PM EDT

Researchers are trying to unravel why some COVID-19 survivors suffer “brain fog” and other problems that can last for months, and new findings suggest some worrisome overlaps with Alzheimer’s disease. One study of older adults in Argentina found a surprising amount...

Medicare evaluating coverage for $56,000 Alzheimer's drug

Jul. 12, 2021 18:33 PM EDT

WASHINGTON (AP) — Medicare on Monday launched a formal process to decide whether to cover Aduhelm, the new Alzheimer's drug whose $56,000-a-year price tag and unproven benefits have prompted widespread criticism and a congressional investigation. A final decision isn't...

FDA head calls for inquiry into Alzheimer's drug review

Jul. 09, 2021 14:39 PM EDT

WASHINGTON (AP) — The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between her agency's drug reviewers and the maker of a controversial new Alzheimer's drug. Dr. Janet Woodcock announced the...

FDA trims use of contentious Alzheimer's drug amid backlash

Jul. 08, 2021 16:39 PM EDT

WASHINGTON (AP) — A month after approving a controversial new Alzheimer’s drug, U.S. health regulators on Thursday signed off on new prescribing instructions that are likely to limit its use. The Food and Drug Administration said the change is intended to address...

Does new Alzheimer's drug work? Answers may miss 2030 target

Jul. 01, 2021 12:03 PM EDT

WASHINGTON (AP) — When a controversial Alzheimer’s drug won U.S. approval, surprise over the decision quickly turned to shock at how long it might take to find out if it really works — nine years. Drugmaker Biogen has until 2030 to complete a study confirming...